公开(公告)号：US20210220367A1

公开(公告)日：2021-07-22

申请号：US17152049

申请日：2021-01-19

申请人： Cai Gu Huang ,  Xiao Qian Wang ,  Ning He

发明人： Cai Gu Huang ,  Xiao Qian Wang ,  Ning He

IPC分类号： A61K31/538 ,  A61K31/40 ,  A61K47/12 ,  A61K47/18 ,  A61K9/00 ,  A61K47/02

摘要： The present invention relates to a liquid pharmaceutical preparation and a method for administering the pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) glycopyrrolate or a salt thereof (b) olodaterol or a salt thereof; (b) a solvent; (c) a pharmacologically acceptable preservative, and (d) a pharmacologically acceptable stabilizer, and optionally other pharmacologically acceptable additives.

公开(公告)号：US20210386730A1

公开(公告)日：2021-12-16

申请号：US17342859

申请日：2021-06-09

申请人： Cai Gu Huang ,  Xiao Qian Wang

发明人： Cai Gu Huang ,  Xiao Qian Wang

IPC分类号： A61K31/4704 ,  A61K31/40 ,  A61K9/00 ,  A61K47/18 ,  A61K47/40 ,  A61M11/00 ,  A61M15/00

摘要： The present invention relates to a liquid pharmaceutical preparation and a method for administering the pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises: (a) glycopyrrolate and indacaterol maleate; (b) a solvent; (c) a pharmacologically acceptable solubilizing agent; (d) a pharmacologically acceptable preservative, (e) a pharmacologically acceptable stabilizer.